Table 1.
Characteristics of included studies
| Reference | Surgical category* | No. of patients | Age (years)† |
Female (%) |
Malignancy (%) |
Duration of hospital stay (days)† | No. of VTE events | Recruitment years |
|---|---|---|---|---|---|---|---|---|
| Agnelli et al.43 | Mixed | 2373 | 64 | 46 | 100 | 10 | 92 | n.r. |
| Kwon et al.31 | General | 4195 | 61 | 54 | 39 | 8 | 47 | 2005–2009 |
| Merkow et al.42 | Mixed | 44 656 | n.r. | 65 | 100 | 4‡ | 719 | 2006–2008 |
| Davenport et al.28 | General | 21 943 | 66 | 49 | 100 | 7‡ | 446 | 2005–2009 |
| Shah et al.36 | Mixed | 471 867 | 54 | 41 | 20 | 4‡ | 7078 | 2005–2010 |
| Tzeng et al.38 | General | 7621 | 60‡ | 52 | 85 | 6‡ | 210 | 2005–2010 |
| Tzeng et al.39 | General | 13 771 | 64‡ | 52 | 82 | 8‡ | 427 | 2005–2010 |
| Lavallée et al.32 | Urological | 2303 | 68 | 21 | 100 | 8‡ | 123 | 2006–2012 |
| VanDlac et al.40 | Urological | 1307 | 69‡ | 24 | 100 | 8‡ | 78 | 2005–2011 |
| Gross et al.41 | General | 37 076 | 66 | 48 | 100 | 10 | 1018 | 2005–2010 |
| Moghadamyeghaneh et al.44 | General | 116 029 | 62 | 52 | n.r. | 6 | 4556 | 2005–2011 |
| Kester et al.45 | Orthopaedic | 23 620 | NR | 61 | 0 | 3‡ | 366 | 2008–2010 |
| Martin et al.33 | General | 3208 | 64‡ | n.r. | 100 | 11‡ | 161 | 2005–2012 |
| Moghadamyeghaneh et al.35 | General | 219 477 | 61 | 52 | 61 | 6 | 2278 | 2005–2013 |
| Spaniolas et al.37 | General | 71 694 | 45‡ | 79 | 0 | n.r. | 283 | 2006–2011 |
| Jordan et al.30 | Urological | 13 208 | 61 | 42 | n.r. | 4‡ | 160 | 2006–2012 |
| McAlpine et al.34 | Urological | 65 100 | n.r. | n.r. | 85 | n.r. | 956 | 2006–2014 |
| Benlice et al.48 | General | 24 182 | 43 | 49 | 0 | 8 | 614 | 2005–2016 |
| Herforth et al.29 | Mixed | 503 602 | n.r. | 51 | n.r. | n.r. | 3912 | 2016 |
| Sager et al.46 | Orthopaedic | 39 825 | 59 | 42 | 0 | n.r. | 102 | 2005–2017 |
| Merhe et al.49 | Urological | 36 753 | 62 | 0 | 100 | 2‡ | 423 | 2008–2015 |
| Kumar et al.47 | General | 141 065 | 57 | 57 | n.r. | 1‡ | 878 | 2011–2017 |
| Total | 1 864 875 | 24 927 |
Details available in supplementary material (Tables S2 and S4). †Mean values are shown, except ‡median. VTE, venous thromboembolism; n.r., not reported.